Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix to Present at the Marcum Microcap Conference on June 16, 2017
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix , is scheduled to speak at the upcoming 2017 Marcum Microcap Conference at the Grand Hyatt Hotel in New York City. Dr.
View HTML
Toggle Summary NeuroMetrix Exhibits Quell Wearable Technology at 31st Annual SLEEP Meeting
Waltham -based company to exhibit its wearable device for widespread chronic pain relief BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc.  (Nasdaq: NURO) is showing  Quell ® , its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world at SLEEP 2017 , the
View HTML
Toggle Summary NeuroMetrix to Present at the LD Micro Invitational Conference on June 6, 2017
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix , is scheduled to speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. Dr.
View HTML
Toggle Summary NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,656,070. The patent covers the novel application of real-time accelerometer measurements to control transcutaneous electrical nerve stimulation.
View HTML
Toggle Summary NeuroMetrix Wins SBANE New England Innovation Award
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) announced that it was the recipient of the Smaller Businesses Association of New England (SBANE) New England Innovation Award for the development and successful launch of Quell ® Wearable Pain Relief Technology™.
View HTML
Toggle Summary NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain
Blog to serve as a resource on issues and topics related to chronic pain, such as digital medicine and alternative treatments WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc . (Nasdaq: NURO) today announced the launch of LivingQuell , a blog that will serve as an online resource for people
View HTML
Toggle Summary Preliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that researchers from the University of Rochester School of Medicine and Dentistry will present a scientific poster titled "Wearable TENs band for chemotherapy-induced peripheral neuropathy (CIPN): A feasibility
View HTML
Toggle Summary NeuroMetrix Announces One-for-Eight Reverse Split
Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted Basis on May 12, 2017 BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017 .
View HTML
Toggle Summary NeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Notices of Allowance has been issued for patents covering key technological features of the Company's Quell ® Wearable Pain Relief Technology™ by the European Patent Office , the Japan Patent Office, and the
View HTML
Toggle Summary NeuroMetrix Hosts Inaugural Quell User Event
Early adopters come together to dialog with the makers of the Quell wearable technology. WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) held its first Quell ® Wearable Pain Relief Technology™ user event last Thursday, April 27 . As a customer-focused company, NeuroMetrix
View HTML